tiprankstipranks
CLEO Diagnostics Ltd (AU:COV)
ASX:COV
Australian Market
COV
CLEO Diagnostics Ltd
RESEARCH TOOLSreports
Want to see AU:COV full AI Analyst Report?

CLEO Diagnostics Ltd (COV) Price & Analysis

4 Followers

COV Stock Chart & Stats

AU$0.60
AU$0.02(5.80%)
At close: 4:00 PM EST
AU$0.60
AU$0.02(5.80%)
Day’s Range― - ―
52-Week RangeAU$0.34 - AU$0.90
Previous CloseN/A
Volume276.00
Average Volume (3M)154.50K
Market Cap
AU$89.64M
Enterprise ValueAU$43.65M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.15
Next Earnings
Sep 02, 2026
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding136,862,090
10 Day Avg. Volume221,880
30 Day Avg. Volume154,495
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A

CLEO Diagnostics Ltd News

Cleo Diagnostics Hits Key U.S. Trial Milestone and Locks In Platform for Ovarian Cancer Test
Cleo Diagnostics Hits Key U.S. Trial Milestone and Locks In Platform for Ovarian Cancer Test
CLEO Diagnostics Ltd ( ($AU:COV) ) has provided an announcement. Cleo Diagnostics has completed sample collection for its...
25d ago
COV
Cleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne
Cleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne
CLEO Diagnostics Ltd ( ($AU:COV) ) has shared an announcement. Cleo Diagnostics has begun a staged manufacturing and...
26d ago
COV
Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test
Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test
CLEO Diagnostics Ltd ( ($AU:COV) ) has shared an update. Cleo Diagnostics has reached a pivotal milestone in...
2M ago
COV
Cleo Diagnostics Finalises Enhanced Biomarker Panel Ahead of FDA Push
Cleo Diagnostics Finalises Enhanced Biomarker Panel Ahead of FDA Push
CLEO Diagnostics Ltd ( ($AU:COV) ) has shared an announcement. Cleo Diagnostics has completed optimisation of the biomarker...
2M ago
COV
Cleo Diagnostics Narrows Asset Gap as Loss Widens on Lower Revenue
Cleo Diagnostics Narrows Asset Gap as Loss Widens on Lower Revenue
CLEO Diagnostics Ltd ( ($AU:COV) ) just unveiled an update. Cleo Diagnostics reported a wider half-year loss of...
3M ago
COV
Cleo Diagnostics Expands U.S. Ovarian Cancer Market Opportunity as Trial Nears Key Milestone
Cleo Diagnostics Expands U.S. Ovarian Cancer Market Opportunity as Trial Nears Key Milestone
CLEO Diagnostics Ltd ( ($AU:COV) ) has shared an update. Cleo Diagnostics reported strong progress in the December...
4M ago
COV
Hudson Institute Investment Holdings Ceases to Be Substantial Holder in CLEO Diagnostics
Hudson Institute Investment Holdings Ceases to Be Substantial Holder in CLEO Diagnostics
CLEO Diagnostics Ltd ( ($AU:COV) ) just unveiled an announcement. Hudson Institute Investment Holdings Pty Ltd has lodged...
5M ago
COV
Cleo Diagnostics Flags Pivotal 2026 After Key Progress on Ovarian Cancer Test
Cleo Diagnostics Flags Pivotal 2026 After Key Progress on Ovarian Cancer Test
CLEO Diagnostics Ltd ( ($AU:COV) ) has provided an update. In an end‑of‑year letter to shareholders, Cleo Diagnostics...
5M ago
COV
Cleo Diagnostics Issues Over 8.3 Million New Shares Without Prospectus
Cleo Diagnostics Issues Over 8.3 Million New Shares Without Prospectus
The latest update is out from CLEO Diagnostics Ltd ( ($AU:COV) ). Cleo Diagnostics Ltd has issued 8,362,084...
5M ago
COV
CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan
CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan
CLEO Diagnostics Ltd ( ($AU:COV) ) has issued an announcement. CLEO Diagnostics has notified the market of the...
5M ago
COV

COV FAQ

What was CLEO Diagnostics Ltd’s price range in the past 12 months?
CLEO Diagnostics Ltd lowest share price was AU$0.34 and its highest was AU$0.90 in the past 12 months.
    What is CLEO Diagnostics Ltd’s market cap?
    CLEO Diagnostics Ltd’s market cap is AU$89.64M.
      When is CLEO Diagnostics Ltd’s upcoming earnings report date?
      CLEO Diagnostics Ltd’s upcoming earnings report date is Sep 02, 2026 which is in 102 days.
        How were CLEO Diagnostics Ltd’s earnings last quarter?
        CLEO Diagnostics Ltd released its earnings results on Feb 25, 2026. The company reported -AU$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.015.
          Is CLEO Diagnostics Ltd overvalued?
          According to Wall Street analysts CLEO Diagnostics Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does CLEO Diagnostics Ltd pay dividends?
            CLEO Diagnostics Ltd does not currently pay dividends.
            What is CLEO Diagnostics Ltd’s EPS estimate?
            CLEO Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does CLEO Diagnostics Ltd have?
            CLEO Diagnostics Ltd has 136,862,090 shares outstanding.
              What happened to CLEO Diagnostics Ltd’s price movement after its last earnings report?
              CLEO Diagnostics Ltd reported an EPS of -AU$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.226%.
                Which hedge fund is a major shareholder of CLEO Diagnostics Ltd?
                Currently, no hedge funds are holding shares in AU:COV
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  CLEO Diagnostics Ltd Stock Smart Score

                  8
                  Outperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Blogger Sentiment

                  Bullish
                  AU:COV Sentiment 100%
                  Sector Average ―

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  8.10%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -49.57%
                  Trailing 12-Months
                  Asset Growth
                  26.25%
                  Trailing 12-Months
                  Top Smart Score Stocks >

                  CLEO Diagnostics Ltd (COV) Earnings & Revenues

                  Historic Earnings Reports

                  Technical Analysis

                  Overall Consensus
                  Buy
                  11Bullish
                  5Neutral
                  6Bearish
                  Bullish
                  Neutral
                  Bearish
                  Overall Consensus
                  11
                  5
                  6
                  Technical Analysis
                  5
                  5
                  0
                  Moving Averages
                  6
                  0
                  6
                  Technical Analysis >
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  BDX
                  BCAL Diagnostics Limited
                  ―
                  ―
                  AT1
                  Atomo Diagnostics Ltd.
                  ―
                  ―
                  LDX
                  Lumos Diagnostics Holdings Ltd.
                  ―
                  ―
                  PIQ
                  Proteomics International Laboratories Ltd.
                  ―
                  ―
                  GSS
                  Genetic Signatures Ltd.
                  ―
                  ―
                  Compare AU:COV Stocks >
                  Popular Stocks